TARO PHAR.INDS. IS 0,0001
TARO PHAR.INDS. IS 0,0001/ IL0010827181 /
TAL
|
28.05.2024 08:03:37
|
Zm.
-0,2000
|
Wolumen |
Bid15:30:14 |
Ask15:30:14 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
39,0000EUR
|
-0,51%
|
0
Obrót: 0.0000 |
-Wolumen Bid: - |
-Wolumen Ask: - |
1,47 mldEUR |
- |
- |
Opis działalności
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.
Zarząd & Rada nadzorcza
| CEO |
| Uday Baldota |
| Zarząd |
| William J. Coote, Vikash Agarwal, Avi Avramoff, Victoria Chester, Anthony Dolan, Moshe Gavrilov, Nivaran Kapur, David Kinzelberg, Karen Lowney, Barb Pimentel, Hagai Reingold, Michele Visosky, Erik Zwicker |
| Rada nadzorcza |
| Dilip Shanghvi, Abhay Gandhi, Uday Baldota, Linda Benshoshan, James Kedrowski, Dr. Robert Stein, Sudhir Valia |
Dane firmy
| Nazwa: |
Taro Pharmaceutical Industrie |
| Adres: |
14 Hakitor Street, Haifa Bay,Haifa 2624761 |
| Telefon: |
+972 4 847 5700 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.taro.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
30.03 |
| Free float: |
- |
| Data IPO: |
01.01.1961 |
